Additionally, ongoing studies suggest that GLP-1 medications may benefit conditions such as non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) by improving insulin sensitivity, reducing inflammation, and positively influencing metabolism
It offers the largest surface area for rotation, consistent subcutaneous fat depth, and reliable absorption rates
Associations of Muscle Mass and Strength with All-Cause Mortality among US Older Adults
Adherence and persistence among patients with type 2 diabetes initiating dulaglutide compared with semaglutide and exenatide BCise: 6-month follow-up from US real-world data
Clinical Pearls: Supporting Patients On or Coming Off GLP-1 Drugs Functional providers are uniquely positioned to support patients tapering off GLP-1s or managing post-medication metabolism
Previnex Probiotic delivers 30 billion healthy bacteria with a clinically proven prebiotic that helps with the growth and colonization of good bacteria in the gut